Free tool
Oncology stocks
We cover 4 companies grouped under the Oncology theme. The median market value in the group is $1.99M. Across the group, the median move over the past trading day is −0.37%. Price change over the past year runs from −99.3% to −49.4% across the middle 80 percent of the group, with a median of −97.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 0RK9.L | Alligator Bioscience AB (publ) | $2.11M | Micro cap | −99.22% |
| ATORX.ST | Alligator Bioscience AB (publ) | $1.88M | Micro cap | −99.30% |
| 0HS8.L | Lisata Therapeutics, Inc. | — | — | −29.74% |
| 0K2H.L | Moleculin Biotech, Inc. | — | — | −95.38% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.